R&D Candidate definition

R&D Candidate has the meaning given to such term in the Collaboration Agreement.
View Source
R&D Candidate. Research and Development Candidate or R&D Candidate shall mean any Antibody to a Specific Target (other than a CAT Exclusive Antibody) that the Joint Steering Committee designates as a R&D Candidate by determining that such Antibody should proceed with GLP toxicology studies.
View Source

Examples of R&D Candidate in a sentence

  • The responsibility for performing clinical studies of each R&D Candidate will be assigned to CAT, ELAN and/or Third Party contractors selected by the JSC in accordance with this Section.

  • Notwithstanding the foregoing, to the extent CAT has or receives any information regarding any adverse drug experience which may be related to the use of any R&D Candidate or Collaboration Product, CAT shall promptly provide ELAN with all such information in accordance with the adverse event reporting procedures to be established by the JSC no later than [***] (as may be amended from time to time upon mutual agreement of the Parties).

  • The term of this Agreement will commence on the Effective Date and, unless earlier terminated as provided in Article 13 or this Article 12, shall continue in full force and effect on a Collaboration Product-by-Collaboration Product and country-by-country basis for so long as any R&D Candidate is being Developed or any Collaboration Product is being sold under this Agreement.

  • Within [***] after the date first written above, ELAN and CAT shall establish a "Joint Steering Committee" or "JSC" to oversee and direct the conduct of Research and the Development of each Specific Target and R&D Candidate and to oversee and coordinate those activities that are necessary for the successful Commercialization for a Collaboration Product in the Territory, as further described below in this Agreement.

  • An R&D Candidate shall remain in the Development Program until such time as (i) the JSC determines that such R&D Candidate should be returned to the Research Program for the conduct of further Research, (ii) such R&D Candidate is dropped from the Development Program or (iii) such R&D Candidate becomes a Collaboration Product.

  • Within [***] after the date first written above, the Parties shall prepare a written annual research plan (the "Annual Research Plan") for the Research activities to be conducted with respect to each Specific Target, any Antibody candidate which bind thereto and each R&D Candidate.

  • If the Research to be conducted under this Agreement, the Development of any R&D Candidate, Manufacture of Clinical Supplies or Collaboration Products and/or Commercialization of any Collaboration Product is alleged by a Third Party to infringe a Third Party's patent or misappropriate a Third Party's Know How, the Party becoming aware of such allegation shall promptly notify the other Party thereof, in writing, reasonably detailing the claim.

  • ELAN shall maintain, and shall cause its permitted Third Party Sublicensees to maintain, the database of clinical trial data accumulated from all clinical trials of R&D Candidate and of adverse reaction information for all such R&D Candidate or Collaboration Products.

  • From time to time, either Party may request an affirmation from the other Party of the status of an Antibody as either an CAT Exclusive Antibody or an R&D Candidate.

  • On a Collaboration Product-by-Collaboration Product basis, not later than [***] after commencement of the first Phase III Clinical Trial of a R&D Candidate in the Territory, ELAN shall prepare and the JSC shall review, and after due consideration by ELAN of any suggestions or comments, accept ELAN's rolling multi-year (being not less than[***]) plan for Commercializing the Collaboration Product in the Territory (the "Commercialization Plan"), which plan shall include without limitation [***].

Related to R&D Candidate

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Product Candidate means, [***].

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid, a quantity of soluble lead compound exceeding, when calculated as lead monoxide, five per cent of the “dry weight” of the portion taken for analysis. In the case of paints and similar products and other mixtures containing oil or fat the “dry weight” means the dry weight of the material remaining after the substance has been thoroughly mixed and treated with suitable solvents to remove oil, fats, varnish or other media.

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).